• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Exploring New Avenues for De Novo Coronary Artery Disease: Next Steps Forward With Drug-Coated Balloons.

作者信息

Kang Dong Oh, Kim Sang-Wook, Jeong Young-Hoon

机构信息

Cardiovascular Center, Department of Internal Medicine, Korea University Guro Hospital, Korea University College of Medicine, Seoul, South Korea.

CAU Thrombosis and Biomarker Center, Chung-Ang University Gwangmyeong Hospital, Gwangmyeong, South Korea.

出版信息

JACC Asia. 2024 Jul 8;4(7):532-535. doi: 10.1016/j.jacasi.2024.05.006. eCollection 2024 Jul.

DOI:10.1016/j.jacasi.2024.05.006
PMID:39101108
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11291394/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f98/11291394/6e17399c1361/ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f98/11291394/6e17399c1361/ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f98/11291394/6e17399c1361/ga1.jpg

相似文献

1
Exploring New Avenues for De Novo Coronary Artery Disease: Next Steps Forward With Drug-Coated Balloons.探索冠状动脉疾病的新途径：药物涂层球囊的下一步进展
JACC Asia. 2024 Jul 8;4(7):532-535. doi: 10.1016/j.jacasi.2024.05.006. eCollection 2024 Jul.
2
Drug-coated balloon versus drug-eluting stent in de novo small coronary vessel disease: A systematic review and meta-analysis.药物涂层球囊与药物洗脱支架治疗初发小冠状动脉疾病的系统评价和荟萃分析
Medicine (Baltimore). 2019 May;98(21):e15622. doi: 10.1097/MD.0000000000015622.
3
Long-Term Follow-Up After Treatment of Drug-Eluting Stent Restenosis and De Novo Lesions Using SeQuent Please Paclitaxel-Coated Balloons.使用SeQuent Please紫杉醇涂层球囊治疗药物洗脱支架再狭窄和新发病变后的长期随访
Angiology. 2019 May;70(5):414-422. doi: 10.1177/0003319718809423. Epub 2018 Nov 1.
4
INtimal hyPerplasia evAluated by oCT in de novo COROnary lesions treated by drug-eluting balloon and bare-metal stent (IN-PACT CORO): study protocol for a randomized controlled trial.OCT 评价药物涂层球囊与金属裸支架治疗初发冠状动脉病变的内膜增生（IN-PACT CORO）：一项随机对照试验的研究方案。
Trials. 2012 May 6;13:55. doi: 10.1186/1745-6215-13-55.
5
Sirolimus-coated balloon versus everolimus-eluting stent in de novo coronary artery disease: Rationale and design of the TRANSFORM II randomized clinical trial.西罗莫司涂层球囊与依维莫司洗脱支架治疗初发冠状动脉疾病：TRANSFORM II 随机临床试验的原理和设计。
Catheter Cardiovasc Interv. 2022 Oct;100(4):544-552. doi: 10.1002/ccd.30358. Epub 2022 Sep 2.
6
Drug-coated balloons versus drug-eluting stents for coronary de novo lesions in dialysis patients.药物涂层球囊与药物洗脱支架治疗透析患者冠状动脉原发病变的比较
Heart Vessels. 2023 Mar;38(3):300-308. doi: 10.1007/s00380-022-02169-x. Epub 2022 Sep 1.
7
Drug-coated balloon for treatment of de-novo coronary artery lesions in patients with high bleeding risk (DEBUT): a single-blind, randomised, non-inferiority trial.药物涂层球囊治疗高出血风险患者新发冠状动脉病变（DEBUT）：一项单盲、随机、非劣效性试验。
Lancet. 2019 Jul 20;394(10194):230-239. doi: 10.1016/S0140-6736(19)31126-2. Epub 2019 Jun 13.
8
Risk of Mortality with Paclitaxel Drug-Coated Balloon in De Novo Coronary Artery Disease.紫杉醇药物涂层球囊用于初发冠状动脉疾病的死亡风险
Cardiovasc Revasc Med. 2020 Apr;21(4):549-555. doi: 10.1016/j.carrev.2020.01.012. Epub 2020 Jan 16.
9
Long-term efficacy of drug coated balloons compared with new generation drug-eluting stents for the treatment of de novo coronary artery lesions.药物涂层球囊与新一代药物洗脱支架治疗新发冠状动脉病变的长期疗效比较。
Catheter Cardiovasc Interv. 2018 Nov 1;92(5):E317-E326. doi: 10.1002/ccd.27548. Epub 2018 Feb 26.
10
The role of drug-eluting balloons alone or in combination with drug-eluting stents in the treatment of de novo diffuse coronary disease.单纯药物球囊或与药物洗脱支架联合治疗初发型弥漫性冠状动脉疾病的作用。
JACC Cardiovasc Interv. 2013 Nov;6(11):1153-9. doi: 10.1016/j.jcin.2013.07.005.

引用本文的文献

1
Pressure-driven microinjection (PMI) of porous-coated balloon for ultrafast endoluminal drug delivery across biological barriers.用于超快腔内药物跨生物屏障递送的多孔涂层球囊的压力驱动微注射（PMI）
Sci Adv. 2025 Jul 11;11(28):eadv1182. doi: 10.1126/sciadv.adv1182. Epub 2025 Jul 9.

本文引用的文献

1
Drug-Coated Balloon Angioplasty for De Novo Lesions on the Left Anterior Descending Artery.药物涂层球囊血管成形术治疗左前降支新发病变。
Circ Cardiovasc Interv. 2023 Dec;16(12):e013232. doi: 10.1161/CIRCINTERVENTIONS.123.013232. Epub 2023 Oct 24.
2
Redefining the way to perform percutaneous coronary intervention: a view in search of evidence.重新定义经皮冠状动脉介入治疗的方式：寻求证据的视角。
Eur Heart J. 2023 Nov 1;44(41):4321-4323. doi: 10.1093/eurheartj/ehad215.
3
Clinical expert consensus document on drug-coated balloon for coronary artery disease from the Japanese Association of Cardiovascular Intervention and Therapeutics.
日本心血管介入治疗学会药物涂层球囊治疗冠状动脉疾病临床专家共识文件
Cardiovasc Interv Ther. 2023 Apr;38(2):166-176. doi: 10.1007/s12928-023-00921-2. Epub 2023 Feb 27.
4
Comparing a strategy of sirolimus-eluting balloon treatment to drug-eluting stent implantation in de novo coronary lesions in all-comers: Design and rationale of the SELUTION DeNovo Trial.比较所有患者中初次冠状动脉病变中应用西罗莫司洗脱球囊治疗与药物洗脱支架植入的策略：SELUTION DeNovo 试验的设计和原理。
Am Heart J. 2023 Apr;258:77-84. doi: 10.1016/j.ahj.2023.01.007. Epub 2023 Jan 13.
5
Clinical Impact of Drug-Coated Balloon-Based Percutaneous Coronary Intervention in Patients With Multivessel Coronary Artery Disease.药物涂层球囊经皮冠状动脉介入治疗在多支冠状动脉疾病患者中的临床影响。
JACC Cardiovasc Interv. 2023 Feb 13;16(3):292-299. doi: 10.1016/j.jcin.2022.10.049. Epub 2023 Jan 4.
6
Sirolimus-coated balloon versus everolimus-eluting stent in de novo coronary artery disease: Rationale and design of the TRANSFORM II randomized clinical trial.西罗莫司涂层球囊与依维莫司洗脱支架治疗初发冠状动脉疾病：TRANSFORM II 随机临床试验的原理和设计。
Catheter Cardiovasc Interv. 2022 Oct;100(4):544-552. doi: 10.1002/ccd.30358. Epub 2022 Sep 2.
7
Drug coated balloons for coronary artery bifurcation lesions: A systematic review and focused meta-analysis.药物涂层球囊治疗冠状动脉分叉病变：系统评价和聚焦荟萃分析。
PLoS One. 2021 Jul 9;16(7):e0251986. doi: 10.1371/journal.pone.0251986. eCollection 2021.
8
Antithrombotic Therapy in Patients With Atrial Fibrillation Treated With Oral Anticoagulation Undergoing Percutaneous Coronary Intervention: A North American Perspective: 2021 Update.接受经皮冠状动脉介入治疗的口服抗凝治疗心房颤动患者的抗栓治疗：北美视角：2021年更新
Circulation. 2021 Feb 9;143(6):583-596. doi: 10.1161/CIRCULATIONAHA.120.050438. Epub 2021 Feb 8.
9
Long-term efficacy and safety of drug-coated balloons versus drug-eluting stents for small coronary artery disease (BASKET-SMALL 2): 3-year follow-up of a randomised, non-inferiority trial.药物涂层球囊与药物洗脱支架治疗小冠状动脉疾病的长期疗效和安全性（BASKET-SMALL 2）：一项随机、非劣效性试验的 3 年随访结果。
Lancet. 2020 Nov 7;396(10261):1504-1510. doi: 10.1016/S0140-6736(20)32173-5. Epub 2020 Oct 19.
10
Impact of coronary lesion complexity in percutaneous coronary intervention: one-year outcomes from the large, multicentre e-Ultimaster registry.经皮冠状动脉介入治疗中冠状动脉病变复杂性的影响：来自大型多中心 e-Ultimaster 注册研究的一年结果。
EuroIntervention. 2020 Sep 18;16(7):603-612. doi: 10.4244/EIJ-D-20-00361.